
CC
Chemours Company (The)
Company Overview
| Mkt Cap | $1.93B | Price | $22.10 |
| Volume | 2.17M | Change | +3.42% |
| P/E Ratio | -5.0 | Open | $21.54 |
| Revenue | $5.8B | Prev Close | $21.37 |
| Net Income | $-386.0M | 52W Range | $9.13 - $50.00 |
| Div Yield | 0.35% | Target | $26.22 |
| Overall | 54 | Value | 60 |
| Quality | 39 | Technical | 63 |
No chart data available
About Chemours Company (The)
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. The company sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Latest News
C&C Group Earnings Call: Brand Strength vs Debt
China Cinda Asset Management Co (CCGDF) Receives a Hold from J.P. Morgan
Credit Clear Updates ASX on Progress of On-Market Share Buy-Back
Cogent Comms Sells U.S. Data Centers to Investor
Cocrystal Pharma Reports Promising Pan-Viral Antiviral Activity
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CC | $22.10 | +3.4% | 2.17M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |